Fig. 3From: Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells VEGF, FLT1, and KDR promoter methylation and expression differences between normal and cancer tissues. Normal, normal tissues; cancer, cancer tissues collected from eight renal cancer patientsBack to article page